Successful tepotinib treatment of adenocarcinoma with MET exon 14 skipping and discordant results between Oncomine Dx target test and ArcherMET: A case report.
Mol Clin Oncol
; 18(6): 49, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-37228358
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Mol Clin Oncol
Year:
2023
Document type:
Article
Affiliation country:
Japón
Country of publication:
Reino Unido